Practice Patterns of Infectious Diseases Physicians in Transitioning From Intravenous to Oral Therapy in Patients With Bacteremia

被引:27
作者
Hospenthal, Duane R. [1 ,2 ]
Waters, C. Dustin [3 ]
Beekmann, Susan E. [4 ]
Polgreen, Philip M. [4 ]
机构
[1] San Antonio Infect Dis Consultants, 8715 Village Dr,Suite 500, San Antonio, TX 78217 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[3] Intermt Healthcare McKay Dee Hosp, Ogden, UT USA
[4] Univ Iowa, Emerging Infect Network, Iowa City, IA USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2020年 / 7卷 / 12期
关键词
bacteremia; oral antibiotics; oral antimicrobial agents; BLOOD-STREAM INFECTIONS; URINARY-TRACT-INFECTIONS; HOSPITALIZED-PATIENTS; ANTIBIOTIC-TREATMENT; DRUG-USERS; VANCOMYCIN; SWITCH; CIPROFLOXACIN; ENDOCARDITIS; MANAGEMENT;
D O I
10.1093/ofid/ofz386
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Bacteremia in adult patients has traditionally been treated with extended courses of intravenous antibiotics. Data on the use of (or rapid transition to) oral therapy are limited. Methods Adult infectious disease physicians participating in the Infectious Diseases Society of America Emerging Infections Network (EIN) were surveyed regarding their use of oral antibiotics in patients with bacteremia. Respondents were asked to assume that patients were hemodynamically stable, recovered bacteria were susceptible to potential antibiotics, adequate source control had been achieved, and patients had adequate gastrointestinal absorption. Variables of specific bacteria, oral agent, and associated infection were included. Results A total of 655 (50%) of 1321 EIN participants responded. Under certain conditions, 88% would transition patients with Gram-negative bacteremia to complete a course of therapy with oral antibiotics; 71% would transition patients with Gram-positive bacteremia to oral agents. Only 78 (12%) respondents would not treat any bacteremic patient with oral agents. Most respondents (>= 75%) were comfortable treating infections secondary to Enterobacteriaceae, Salmonella, Pseudomonas, Stenotrophomonas, Streptococcus pneumoniae, and beta-hemolytic streptococci with oral agents. Fewer than 20% endorsed use of oral antibiotics for Staphylococcus aureus or in cases of endocarditis. Fluoroquinolones and trimethoprim-sulfamethoxazole were the preferred agents in Gram-negative bacteremia; linezolid and beta-lactams were the preferred agents in Gram-positive bacteremia. Conclusions In select circumstances, the majority of respondents would transition patients to oral antibiotics, in both Gram-negative and Gram-positive bacteremia. Most agreed with the use of oral agents in Gram-negative bacteremia caused by Enterobacteriaceae, but they would not use oral agents for Gram-positive bacteremia caused by S aureus or in endocarditis.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 31 条
  • [1] Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review
    Al-Omari, Awad
    Cameron, D. William
    Lee, Craig
    Corrales-Medina, Vicente F.
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [2] Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients
    Britt, Nicholas S.
    Potter, Emily M.
    Patel, Nimish
    Steed, Molly E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) : 871 - 878
  • [3] Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort
    Chotiprasitsakul, Darunee
    Han, Jennifer H.
    Cosgrove, Sara E.
    Harris, Anthony D.
    Lautenbach, Ebbing
    Conley, Anna T.
    Tolomeo, Pam
    Wise, Jacqueleen
    Tamma, Pranita D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (02) : 172 - 177
  • [4] Management of bloodstream infections by infection specialists in France and Germany: a cross-sectional survey
    Diallo, Kevin
    Kern, Winfried V.
    de With, Katja
    Luc, Amandine
    Thilly, Nathalie
    Pulcini, Celine
    [J]. INFECTION, 2018, 46 (03) : 333 - 339
  • [5] Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey
    Diallo, Kevin
    Thilly, Nathalie
    Luc, Amandine
    Beraud, Guillaume
    Ergonul, Onder
    Giannella, Maddalena
    Kofteridis, Diamantis
    Kostyanev, Tomislav
    Pano-Pardo, Jose Ramon
    Retamar, Pilar
    Kern, Winfried
    Pulcini, Celine
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (05) : 794 - 798
  • [6] DWORKIN RJ, 1989, LANCET, V2, P1071
  • [7] Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials
    Eliakim-Raz, Noa
    Yahav, Dafna
    Paul, Mical
    Leibovici, Leonard
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (10) : 2183 - 2191
  • [8] Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe
    Goto, M.
    Al-Hasan, M. N.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (06) : 501 - 509
  • [9] When are Oral Antibiotics a Safe and Effective Choice for Bacterial Bloodstream Infections? An Evidence-Based Narrative Review
    Hale, Andrew J.
    Snyder, Graham M.
    Ahern, John W.
    Eliopoulos, George
    Ricotta, Daniel N.
    Alston, W. Kemper
    [J]. JOURNAL OF HOSPITAL MEDICINE, 2018, 13 (05) : 328 - 335
  • [10] Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: Prospective randomized comparison with parenteral therapy
    Heldman, AW
    Hartert, TV
    Ray, SC
    Daoud, EG
    Kowalski, TE
    Pompili, VJ
    Sisson, SD
    Tidmore, WC
    Eigen, KAV
    Goodman, SN
    Lietman, PS
    Petty, BG
    Flexner, C
    [J]. AMERICAN JOURNAL OF MEDICINE, 1996, 101 (01) : 68 - 76